![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Pharmacokinetics (PK) of Etravirine (ETR) in HIV-1-Infected Pregnant Women
|
|
|
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy; May 26-28, 2015; Washington, DC, USA.
Crauwels HM,1,* Baugh B,2 Ryan R,3 Zorrilla C,4 Osiyemi OO,5 Yasin S,6 Brown K,2 Verboven P,7 Hillewaert V,7 Kakuda TN3
1Janssen Infectious Diseases, Beerse, Belgium; 2Janssen Scientific Affairs, Titusville, NJ, USA; 3Janssen Research & Development, Titusville, NJ, USA; 4University of Puerto Rico School of Medicine, San Juan, Puerto Rico; 5Triple O Research Institute PA, West Palm Beach, FL, USA; 6University of Miami School of Medicine, Miami, FL, USA; 7Janssen Research & Development, Beerse, Belgium.
![pharm1.gif](../images/060215/060215-4/pharm1.gif)
![pharm2.gif](../images/060215/060215-4/pharm2.gif)
![pharm3.gif](../images/060215/060215-4/pharm3.gif)
![pharm4.gif](../images/060215/060215-4/pharm4.gif)
![pharm5.gif](../images/060215/060215-4/pharm5.gif)
![pharm6.gif](../images/060215/060215-4/pharm6.gif)
![pharm7.gif](../images/060215/060215-4/pharm7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|